Association of sodium-glucose cotransporter-2 inhibitor use and mortality in patients with endometrial cancer: a retrospective cohort study

Abstract Background Endometrial cancer is closely linked to obesity and type 2 diabetes mellitus (T2DM). Sodium-glucose cotransporter-2 inhibitors (SGLT2i), originally developed for diabetes, demonstrate potential anti-cancer properties. This study aims to investigate the association between SGLT2i...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Min Wang, Mingxia Ye, Maria Lucero, Wanchun Pan, Xin Wang, Heping Zhang, Ling Zhou, Yuanguang Meng
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2025-07-01
Schriftenreihe:	BMC Cancer
Schlagworte:	Sodium-glucose cotransporter-2 inhibitor Endometrial cancer Mortality
Online-Zugang:	https://doi.org/10.1186/s12885-025-14453-w
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!